Compare XRPN & PALI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | XRPN | PALI |
|---|---|---|
| Founded | 2024 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 321.3M | 311.8M |
| IPO Year | N/A | N/A |
| Metric | XRPN | PALI |
|---|---|---|
| Price | $10.23 | $2.02 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $17.67 |
| AVG Volume (30 Days) | 194.4K | ★ 5.9M |
| Earning Date | 01-01-0001 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.11 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $94.94 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.00 | $0.53 |
| 52 Week High | $10.91 | $2.64 |
| Indicator | XRPN | PALI |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 48.65 |
| Support Level | N/A | $2.24 |
| Resistance Level | N/A | $2.55 |
| Average True Range (ATR) | 0.00 | 0.21 |
| MACD | 0.00 | -0.01 |
| Stochastic Oscillator | 0.00 | 35.60 |
Armada Acquisition Corp II is a blank check company.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.